Use cautionMedical device recall · FDA · Published February 9, 2023
FreeStyle Libre 3 App on Android 13: Signal Loss Risk
Abbott recalls FreeStyle Libre 3 app for Android 13 OS versions 3.4.0 and below due to potential signal loss causing undetected glucose levels. Users may need to update or switch OS.
If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
Take action
Contact the company
📍Recalling firmAbbott Diabetes Care, Inc.1360 S Loop Rd · Alameda, CA 94502-7000
✎ GovInfoNow plain-language explainer
Abbott is recalling the FreeStyle Libre 3 app for Android 13 OS versions 3.4.0 and below because signal loss can cause missed glucose readings. This could lead to dangerous high or low blood sugar levels if not treated properly. Read more at govinfonow.com/recall/58919-freestyle-libre-3-app-on-android-13-signal-loss-risk.
“FreeStyle Libre 3 App on Android 13: Signal Loss Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58919-freestyle-libre-3-app-on-android-13-signal-loss-risk. Based on FDA recall #Z-0734-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0734-2024%22&limit=1).
The FDA announced on Feb. 9, 2023, that Abbott Diabetes Care is recalling the FreeStyle Libre 3 App for use on Android 13 due to signal loss risks. The recall affects approximately 45,173 units distributed nationwide.
How to tell if you have it
FreeStyle Libre 3 App
Continuous Glucose Monitoring System
Android 13 Operating System
UDI-DI: 00357599816001
Software v.3.4.0 and below
The hazard
Extended periods of signal loss may occur because the app is not connected, potentially impacting the ability to receive glucose readings or alarms. This could lead to undetected low or high glucose levels and result in delayed treatment, such as failing to take insulin for high glucose or glucose for low glucose.
Context
GovInfoNow's records show Abbott Diabetes Care has five other recalls on record since Nov. 14, 2019. Other recent recalls of similar products include FreeStyle Libre 3 Plus Sensor Recall (Nov. 24, 2025), Abbott FreeStyle Libre 3 Sensors (July 24, 2024), and FreeStyle Libre 2 Readers (July 12, 2023). Other recent recalls of similar products include Tandem t:slim App Recall (July 16, 2026) and Dexcom G7 CGM App recalls (April 14, 2026).
How to tell if you have this one
Check if you have the FreeStyle Libre 3 app installed on Android 13 OS versions 3.4.0 and below. The unique identifier (UDI-DI) is 00357599816001.
Brand
Abbott Diabetes Care
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Update the App
Update the FreeStyle Libre 3 app to version 3.4.1 or later for Android 13 OS.
Check Device Compatibility
Ensure your device runs Android 13 OS with the updated app version to avoid signal loss.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 19 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Florida, Indiana, Iowa, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Utah, Virginia.
Recall timeline
FDA published this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0734-2024 (February 9, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0734-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.